Home Twists and turns: The whirl sign in a patient with systemic sclerosis
Article Open Access

Twists and turns: The whirl sign in a patient with systemic sclerosis

  • Lin Qiao EMAIL logo and Dong Xu
Published/Copyright: October 21, 2024
Become an author with De Gruyter Brill

A 36-year-old female was admitted because of progressive skin thickening for 9-years. During the past9 years, she experienced Raynaud’s phenomenon, facial and extremity skin thickening, exertional dyspnea, abdominal distension, and muscle pain along with time. Her serologic investigation revealed a positive anti-nuclear antibody with a titre of 1: 80 in a homogeneous pattern. The patient was diagnosed as having limited systemic sclerosis (SSc) with lung and gastrointestinal involvement. Low-dose glucocorticoid combined with azathioprine were initiated. She had intermittent diarrhea with abdominal distension in the past 4 months and she was diagnosed as pseudo-obstruction (IPO). Ultrasound examination revealed thickened small intestine wall with evident intestinal dilation. A subsequent abdominal computed tomography (CT) scan revealed dilated fluid-filled bowel loops, with thickened bowel wall and an unusual mesenteric presentation. The mesentery was twisted and there was diffuse engorgement of the mesenteric vessels along with diffuse haziness. CT revealed a whirl sign of mesentery and wrapped small bowel loops (Figure 1). She was treated with fasting and total parenteral nutrition were initiated to improve her nutrition. She was temporarily started on oral prednisolone (20 mg/d), intravenous cyclophosphamide (0.4 g/week), monthly immunoglobulin (400 mg/kg over 3 days) and probiotics. An improvement in bowel motility was observed. Abdominal X-ray image demonstrated a decrease in intestinal gas. Then she resumed semiliquid diets gradually, and received six courses (400 mg/kg over 3 days) of immunoglobulin infusion, and her glucocortoid were tapered. Cyclophosphamide infusion was withdrawn due to severe thrombocytopenia. Six months later, her abdominal symptoms and muscle pain improved, and her body weight increased from 38 kg to 42 kg.

Figure 1 
Computed tomography scan of the abdominal. The whirl sign (arrow) under abdominal X-ray (A and B) before treatment (C) and six months after treatment (D).
Figure 1

Computed tomography scan of the abdominal. The whirl sign (arrow) under abdominal X-ray (A and B) before treatment (C) and six months after treatment (D).

Patients with SSc can experience a variety of gastrointestinal dysmotility starting from the esophagus to the anorectum.[1,2] In patients with SSc, chronic IPO, which is characterized by clinical and radiological evidence of chronic episodic intestinal obstruction in the absence of a mechanical lesion, presents as a dilated and atonic small bowel with delayed transit. The whirl sign, which is characterized with a spiraled loop of collapsed bowel and engorged mesenteric vessels on a CT scan is an important sign for the diagnosis of volvulus. However, there is no evidence that showed the effectiveness of immunosuppressive therapy in this condition. Previous investigations[3,4] suggested that immunoglobulin infusion might be beneficial. In our case, her condition was improved after being treated with immunoglobulin infusion and control of oral intake.


Address for correspondence: *Lin Qiao, Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences & Peking Union Medical College; National Clinical Research Center for Dermatologic and Immunologic Disease (NCRC-DID), Ministry of Science & Technology; State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH); Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing 100730, China.

Funding statement: None.

Acknowledgement

None.

  1. Author contributions

    Lin Qiao wrote the paper and edited the images. Dong Xu proofread the paper before submission.

  2. Informed consent

    Images are de-identified; however the patients has signed her consent to the publication of the images, her data and her clinical history.

  3. Ethical approval

    Ethical approval was obtained from the institutional ethical committee.

  4. Conflict of interest

    All authors declare no conflict of interest.

  5. Data availability statement

    No additional data is available.

References

[1] Rheumatic diseases clinics of North America. 2015;41:459-473.10.1016/j.rdc.2015.04.007Search in Google Scholar PubMed

[2] Kaniecki T, Abdi T, McMahan ZH. A practical approach to the evaluation and management of gastrointestinal symptoms in patients with systemic sclerosis. Best Pract Res Clin Rheumatol. 2021;35:101666.10.1016/j.berh.2021.101666Search in Google Scholar PubMed PubMed Central

[3] Tandaipan J, Guillen-Del-Castillo A, Simeon-Aznar CP, et al. Immunoglobulins in systemic sclerosis management. A large multicenter experience. Autoimmunity reviews. 2023;22:103441.10.1016/j.autrev.2023.103441Search in Google Scholar PubMed

[4] Matsuda KM, Yoshizaki A, Kuzumi A, et al. Rapid improvement of systemic sclerosis-associated intestinal pseudo-obstruction with intravenous immunoglobulin administration. Rheumatology. 2023;62:3139-3145.10.1093/rheumatology/kead093Search in Google Scholar PubMed PubMed Central

Received: 2024-08-09
Accepted: 2024-08-24
Published Online: 2024-10-21

© 2024 Lin Qiao, Dong Xu, published by De Gruyter on behalf of NCRC-DID

This work is licensed under the Creative Commons Attribution 4.0 International License.

Downloaded on 26.10.2025 from https://www.degruyterbrill.com/document/doi/10.2478/rir-2024-0025/html
Scroll to top button